Medicenna Therapeutics (MDNAF) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
MDNAF is expected to report earnings to rise 34.08% to -4 cents per share on February 06
Q4'24
Est.
$-0.05
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.03
Q1'24
Missed
by $0.01
Q4'23
Est.
$-0.05
The last earnings report on November 15 showed earnings per share of -3 cents, beating the estimate of -4 cents. With 50.24K shares outstanding, the current market capitalization sits at 98.28M.